48 results
8-K
EX-99.1
RLYB
Rallybio Corporation
8 Aug 24
Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates
8:05am
with a team of highly dedicated investigators who share our mission to prevent this devastating disease."
Recent Business Highlights and Upcoming … with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline
8-K
EX-99.1
RLYB
Rallybio Corporation
9 May 24
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
8:11am
collaboration with Johnson & Johnson, marking a significant step forward in our mission to eliminate FNAIT and its devastating consequences. Together … -stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio
8-K
EX-99.1
4to8n
10 Apr 24
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
xck7cnq
12 Mar 24
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
8:11am
8-K
EX-99.1
o50xqa0
6 Feb 24
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
8:15am
8-K
EX-99.1
tpztkb
20 Dec 23
Regulation FD Disclosure
8:15am
8-K
EX-99.1
8s5fzaja iim
9 Nov 23
Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates
8:10am
8-K
EX-99.1
xd17uchg6wundi
8 Aug 23
Rallybio Reports Second Quarter 2023 Financial Results and Provides Business Updates
8:16am
8-K
EX-99.1
hno1wnvkxvrvmvqnpkc
29 Jun 23
Departure of Directors or Certain Officers
7:30am
424B3
t01ndq9tx
12 May 23
Prospectus supplement
4:50pm
8-K
EX-99.1
aa8qd kgv6o9
9 May 23
Rallybio Reports First Quarter 2023 Financial Results
8:11am